Compare Cardinal Health Inc (CAH) vs CleanSpark Inc (CLSK) Price & Performance

Cardinal Health (CAH) trades at $236.87, down 0.13% on the day, near its 52-week high. The stock shows strong momentum with four consecutive quarterly EPS beats, including Q2 2026 EPS of $2.91 versus $2.42 expected. Technical indicators are bullish overall, with moving averages supporting upward trends. Revenue reached $222.58 billion in 2025, with net income margin improving to 0.67%.

Outlook remains positive driven by robust pharmaceutical demand and optimistic FY2027 guidance. Key risks include high debt levels and thin profit margins. Analysts maintain a bullish consensus with a $266.43 price target, representing 12.5% upside. The stock presents a growth opportunity but requires monitoring of margin pressures and cash flow volatility.

CleanSpark (CLSK) trades at $12.23, up 5.52% today but showing bearish technical signals with recent earnings misses. The company reported a Q3 2026 loss of $0.89 per share versus expectations of $0.47, continuing a trend of negative profitability despite securing a significant $6.6 billion AI data center lease. Revenue declined to $679 million in 2026 with a negative profit margin of -146.91%, though analyst consensus remains unanimously bullish with a $24.13 price target.

The stock presents a high-risk opportunity with strong institutional support but significant fundamental challenges. While the AI infrastructure pivot offers long-term potential, near-term execution risks and persistent losses require careful monitoring. The 100% buy rating from analysts suggests confidence in the strategic shift, but investors must weigh the substantial valuation premium against ongoing cash burn and competitive pressures.